IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Personalized medicine is reshaping laboratory costs and services, impacting growth and competitive strategies. Demand is rising for laboratories capable of advanced genetic testing, which requires sophisticated technology and specialized expertise in genetic data analysis. Although these tests carry high upfront costs, they can lower long-term healthcare expenses and increase the clinical value of laboratory services. As demand rises, laboratories' operating expenses are climbing, increasing the benefits of consolidation. Mergers enable lab networks to capture economies of scale, invest in new technologies and offer more comprehensive testing menus. While new technologies like point-of-care testing (POCT) present ongoing competitive challenges, industry revenue has grown at a slower CAGR of 0.4% to reach $88.7 billion through 2026, reflecting strong growth earlier in the period. The industry is experiencing a 3.0% gain in 2026 alone, with profit increasing.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Diagnostic & Medical Laboratories industry in the United States includes market sizing, forecasting, data and analysis from 2016-2031. The most recent publication was released February 2026.
The Diagnostic & Medical Laboratories industry in the United States operates under the NAICS industry code 62151. Laboratories in this industry provide analytic services to identify or determine the nature and cause of a disease or injury by evaluating a patient’s history, examination and data. These services are provided to healthcare providers or patients upon referral from health practitioners. Related terms covered in the Diagnostic & Medical Laboratories industry in the United States include anatomical pathology test, computed tomography (ct) , capitated payment contract, magnetic resonance imaging (mri), managed-care organization (mco) , medicare, medicaid , diagnosis-related group (drg), outpatient prospective payment system (opps), positron emission tomography (pet), esoteric tests and genomics.
Products and services covered in Diagnostic & Medical Laboratories industry in the United States include General pathology services, Clinical pathology services and MRI imaging.
Companies covered in the Diagnostic & Medical Laboratories industry in the United States include Quest Diagnostics Inc. and Laboratory Corporation Of America Holdings.
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Diagnostic & Medical Laboratories industry in the United States.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
The Products and Markets chapter covers detailed products and service segmentation and analysis of major markets for the for the Diagnostic & Medical Laboratories industry in the United States.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Diagnostic & Medical Laboratories industry in the United States.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Diagnostic & Medical Laboratories industry in the United States. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
The Companies chapter covers Key Takeaways, Market Share and Companies in the Diagnostic & Medical Laboratories industry in the United States. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Diagnostic & Medical Laboratories industry in the United States. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Diagnostic & Medical Laboratories industry in the United States. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Diagnostic & Medical Laboratories industry in the United States.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The market size of the Diagnostic & Medical Laboratories industry in the United States is $86.0bn in 2026.
There are 34,875 businesses in the Diagnostic & Medical Laboratories industry in the United States, which has grown at a CAGR of 3.6 % between 2021 and 2026.
The Diagnostic & Medical Laboratories industry in the United States is unlikely to be materially impacted by import tariffs with imports accounting for a low share of industry revenue.
The Diagnostic & Medical Laboratories industry in the United States is unlikely to be materially impacted by export tariffs with exports accounting for a low share of industry revenue.
The market size of the Diagnostic & Medical Laboratories industry in the United States has been declining at a CAGR of 0.2 % between 2021 and 2026.
Over the next five years, the Diagnostic & Medical Laboratories industry in the United States is expected to grow.
The biggest companies operating in the Diagnostic & Medical Laboratories industry in the United States are Quest Diagnostics Inc. and Laboratory Corporation Of America Holdings
General pathology services and Clinical pathology services are part of the Diagnostic & Medical Laboratories industry in the United States.
The company holding the most market share in the Diagnostic & Medical Laboratories industry in the United States is Quest Diagnostics Inc..
The level of competition is high and steady in the Diagnostic & Medical Laboratories industry in the United States.